Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.38 |
| ▸ | HTR4 | Q13639 | 3/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | TACR1 | P25103 | 6/20 | 0.38 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL573693 | 0.84 | QPCT (0.39) | QPCTSLC6A4SLC6A2SLC6A3TACR1 | |
| SCHEMBL27808000 | 0.83 | TACR1 (0.40) | SLC6A4SLC6A2SLC6A3TACR1MEN1 | |
| SCHEMBL4439262 | 0.81 | EPHX2 (0.39) | SLC6A4SLC6A2HTR4SLC6A3TACR1 | |
| SCHEMBL574274 | 0.81 | EHMT2 (0.39) | QPCTSLC6A4SLC6A2HTR4SLC6A3 | |
| SCHEMBL27906127 | 0.80 | SLC6A4 (0.36) | SLC6A4SLC6A2SLC6A3TACR1 | |
| SCHEMBL17560116 | 0.79 | TACR1 (0.41) | SLC6A4SLC6A2SLC6A3TACR1MEN1 | |
| SCHEMBL28952936 | 0.78 | TACR1 (0.40) | SLC6A4SLC6A2SLC6A3TACR1MEN1 | |
| SCHEMBL4439470 | 0.78 | MEN1 (0.36) | SLC6A4SLC6A2SLC6A3TACR1MEN1 | |
| SCHEMBL12469312 | 0.78 | SLC6A2 (0.46) | SLC6A4SLC6A2SLC6A3TACR1MEN1 | |
| SCHEMBL27539398 | 0.76 | ALDH1A1 (0.42) | MEN1KMT2AALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2601186-A2 | 4-(1H-INDOL-3-YL)-PYRIMIDINES AS ALK INHIBITORS | AstraZeneca AB (SE) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012017239-A2 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2012-02-09 | — | — | WO | disclosed |